Real-time enrollment status for this solid tumor, adult clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:00 PM UTC
| NCT Number | NCT06625775 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor, Adult |
| Phase | PHASE1 |
| Target Enrollment | 392 participants |
| Active Locations | 19 sites in the US |
| Sponsor | TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) |
| Last Updated on CT.gov | October 1, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT06625775 is currently recruiting participants. This phase1 study for solid tumor, adult is actively seeking new participants at 19 locations across the United States. The study is sponsored by TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06625775 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06625775 was last updated 1 week ago (October 1, 2026). HelloStudys verifies this status automatically.